Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP235722.RAzAOh-FOml0z_sPiHlMS9330cMlpJJgEiEZHnw2Fk7yE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP235722.RAzAOh-FOml0z_sPiHlMS9330cMlpJJgEiEZHnw2Fk7yE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP235722.RAzAOh-FOml0z_sPiHlMS9330cMlpJJgEiEZHnw2Fk7yE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP235722.RAzAOh-FOml0z_sPiHlMS9330cMlpJJgEiEZHnw2Fk7yE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP235722.RAzAOh-FOml0z_sPiHlMS9330cMlpJJgEiEZHnw2Fk7yE130_provenance.
- NP235722.RAzAOh-FOml0z_sPiHlMS9330cMlpJJgEiEZHnw2Fk7yE130_assertion wasGeneratedBy ECO_0000203 NP235722.RAzAOh-FOml0z_sPiHlMS9330cMlpJJgEiEZHnw2Fk7yE130_provenance.
- NP235722.RAzAOh-FOml0z_sPiHlMS9330cMlpJJgEiEZHnw2Fk7yE130_assertion wasDerivedFrom befree-20150227 NP235722.RAzAOh-FOml0z_sPiHlMS9330cMlpJJgEiEZHnw2Fk7yE130_provenance.
- NP235722.RAzAOh-FOml0z_sPiHlMS9330cMlpJJgEiEZHnw2Fk7yE130_assertion SIO_000772 24756793 NP235722.RAzAOh-FOml0z_sPiHlMS9330cMlpJJgEiEZHnw2Fk7yE130_provenance.
- NP235722.RAzAOh-FOml0z_sPiHlMS9330cMlpJJgEiEZHnw2Fk7yE130_assertion evidence source_evidence_literature NP235722.RAzAOh-FOml0z_sPiHlMS9330cMlpJJgEiEZHnw2Fk7yE130_provenance.
- NP235722.RAzAOh-FOml0z_sPiHlMS9330cMlpJJgEiEZHnw2Fk7yE130_assertion description "[The high efficacy of crizotinib in ALK- and ROS-positive lung cancer as new molecular targets beside the epidermal growth factor receptor (EGFR) underscores the importance of molecular typing in NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235722.RAzAOh-FOml0z_sPiHlMS9330cMlpJJgEiEZHnw2Fk7yE130_provenance.